Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001181431-13-039584
Filing Date
2013-07-11
Accepted
2013-07-11 17:01:23
Documents
2
Period of Report
2013-07-09

Document Format Files

Seq Description Document Type Size
1 FORM 3 rrd385637.html 3  
1 FORM 3 rrd385637.xml 3 8129
2 POWER OF ATTORNEY rrd346851_392347.htm EX-24.1 3650
  Complete submission text file 0001181431-13-039584.txt   13167
Mailing Address 2929 SEVENTH STREET SUITE 100 BERKELEY CA 94710
Business Address 2929 SEVENTH STREET SUITE 100 BERKELEY CA 94710 5108485100
DYNAVAX TECHNOLOGIES CORP (Issuer) CIK: 0001029142 (see all company filings)

EIN.: 330728374 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O DYNAVAX TECHNOLOGIES 2929 SEVENTH STREET, SUITE 100 BERKELEY CA 94710
Business Address
Janssen Robert (Reporting) CIK: 0001580849 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-34207 | Film No.: 13964368